Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Thoracic Cancer|June 30, 2022
Pericancerous lymph node imaging with indocyanine green-guided near-infrared fluorescence in radical esophagectomy: Protocol for a single-center, prospective, randomized controlled clinical trialJianting Du, Guobing Xu, Zhang Yang, et al.Journal of Environmental Monitoring : JEM|July 15, 2011
Centrifugal study of zone of influence during air-spargingLiming Hu, Jay N Meegoda, Jianting Du, et al.Cancers|January 26, 2024
CRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer ResearchXian Gong, Jianting Du, Ren-Wang Peng, et al.Oncology Reports|July 11, 2025
Harnessing CRISPR/Cas9 to overcome targeted therapy resistance in non‑small cell lung cancer: Advances and challenges (Review)Jianting Du, Xian Gong, Renjie Huang, et al.International Journal of General Medicine|December 3, 2021
miR-21-5p is a Biomarker for Predicting Prognosis of Lung Adenocarcinoma by Regulating PIK3R1 ExpressionJianting Du, Jiekun Qian, Bin Zheng, et al.Cancer Medicine|June 11, 2022
Cost-effectiveness of osimertinib versus placebo in resected EGFR-mutated non-small cell lung cancer in ChinaXiwen Zhou, Jianting Du, Guobing Xu, et al.Translational Cancer Research|February 4, 2022
Intersegmental plane simulation based on the bronchus-vein-artery triad in pulmonary segmentectomyGuobing Xu, Jianting Du, Chun Chen, et al.Thoracic Cancer|April 28, 2022
A propensity sore-matched study: Applying a modified chest tube drainage strategy in rapid rehabilitation following uni-portal thoracoscopic pulmonary wedge resectionGuobing Xu, Jianting Du, Jiarong Zhang, et al.Oncology Letters|September 25, 2024
Perioperative serplulimab‑based chemoimmunotherapy in stage IV large cell neuroendocrine carcinoma of the lung: A case reportShuliang Zhang, Jianting Du, Chuanquan Lin, et al.Thoracic Cancer|September 8, 2023
miR-1301-3p promotes invasion and migration and EMT progression in esophageal cancer by downregulating NBL1 expressionJianting Du, Shuliang Zhang, Xiaodan Zhang, et al.Pageof 2